Financhill
Sell
45

AVNS Quote, Financials, Valuation and Earnings

Last price:
$12.36
Seasonality move :
0.21%
Day range:
$11.87 - $12.38
52-week range:
$9.30 - $17.69
Dividend yield:
0%
P/E ratio:
45.94x
P/S ratio:
0.82x
P/B ratio:
0.74x
Volume:
575.8K
Avg. volume:
532.9K
1-year change:
-19.81%
Market cap:
$573.3M
Revenue:
$687.8M
EPS (TTM):
-$10.19

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
AVNS
Avanos Medical, Inc.
$174.7M $0.25 -2.73% 30.01% $14.00
IVF
INVO Fertility, Inc.
$1.9M -- -8.8% -- --
NMTC
NeuroOne Medical Technologies Corp.
$2.7M -- -57.64% -57.14% $2.30
NTRB
Nutriband, Inc.
$675K -$0.17 4.52% -54.85% $15.00
NVNO
enVVeno Medical Corp.
-- -$0.28 -- -9.68% $12.50
SINT
SINTX Technologies, Inc.
$300K -$0.55 -44.65% -56.43% $12.25
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
AVNS
Avanos Medical, Inc.
$12.35 $14.00 $573.3M 45.94x $0.00 0% 0.82x
IVF
INVO Fertility, Inc.
$0.85 -- $12.9M -- $0.00 0% 0.02x
NMTC
NeuroOne Medical Technologies Corp.
$0.88 $2.30 $44.2M -- $0.00 0% 2.91x
NTRB
Nutriband, Inc.
$4.37 $15.00 $53.1M -- $0.00 0% 21.81x
NVNO
enVVeno Medical Corp.
$0.36 $12.50 $7.3M -- $0.00 0% 473.07x
SINT
SINTX Technologies, Inc.
$3.78 $12.25 $14.6M -- $0.00 0% 6.41x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
AVNS
Avanos Medical, Inc.
14.67% 0.742 24.92% 1.26x
IVF
INVO Fertility, Inc.
41.99% 0.410 10.12% 0.07x
NMTC
NeuroOne Medical Technologies Corp.
3.64% 3.209 0.6% 3.40x
NTRB
Nutriband, Inc.
3.31% 3.036 0.32% 7.07x
NVNO
enVVeno Medical Corp.
2.62% 2.708 4.32% 12.90x
SINT
SINTX Technologies, Inc.
45.47% 0.781 22.94% 1.47x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
AVNS
Avanos Medical, Inc.
$81.1M $13.1M -44.75% -52.63% 7.37% $7M
IVF
INVO Fertility, Inc.
$492.6K -$1.6M -188.23% -471.28% -93.08% -$1.8M
NMTC
NeuroOne Medical Technologies Corp.
$1.5M -$1.4M -83.42% -89.54% -50.02% -$1.5M
NTRB
Nutriband, Inc.
$63K -$3.9M -159.71% -164.64% -1121.15% -$1.8M
NVNO
enVVeno Medical Corp.
-$120K -$4.9M -56.26% -57.7% -- -$4.4M
SINT
SINTX Technologies, Inc.
-$66K -$3.4M -115.95% -208.36% -1612.98% -$2.6M

Avanos Medical, Inc. vs. Competitors

  • Which has Higher Returns AVNS or IVF?

    INVO Fertility, Inc. has a net margin of -0.79% compared to Avanos Medical, Inc.'s net margin of -150.51%. Avanos Medical, Inc.'s return on equity of -52.63% beat INVO Fertility, Inc.'s return on equity of -471.28%.

    Company Gross Margin Earnings Per Share Invested Capital
    AVNS
    Avanos Medical, Inc.
    45.61% -$0.03 $911.7M
    IVF
    INVO Fertility, Inc.
    28.04% -$6.14 $10.1M
  • What do Analysts Say About AVNS or IVF?

    Avanos Medical, Inc. has a consensus price target of $14.00, signalling upside risk potential of 13.36%. On the other hand INVO Fertility, Inc. has an analysts' consensus of -- which suggests that it could grow by 16797.44%. Given that INVO Fertility, Inc. has higher upside potential than Avanos Medical, Inc., analysts believe INVO Fertility, Inc. is more attractive than Avanos Medical, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    AVNS
    Avanos Medical, Inc.
    0 1 0
    IVF
    INVO Fertility, Inc.
    0 0 0
  • Is AVNS or IVF More Risky?

    Avanos Medical, Inc. has a beta of 1.079, which suggesting that the stock is 7.932% more volatile than S&P 500. In comparison INVO Fertility, Inc. has a beta of 2.606, suggesting its more volatile than the S&P 500 by 160.551%.

  • Which is a Better Dividend Stock AVNS or IVF?

    Avanos Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. INVO Fertility, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avanos Medical, Inc. pays -- of its earnings as a dividend. INVO Fertility, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios AVNS or IVF?

    Avanos Medical, Inc. quarterly revenues are $177.8M, which are larger than INVO Fertility, Inc. quarterly revenues of $1.8M. Avanos Medical, Inc.'s net income of -$1.4M is higher than INVO Fertility, Inc.'s net income of -$2.6M. Notably, Avanos Medical, Inc.'s price-to-earnings ratio is 45.94x while INVO Fertility, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avanos Medical, Inc. is 0.82x versus 0.02x for INVO Fertility, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    AVNS
    Avanos Medical, Inc.
    0.82x 45.94x $177.8M -$1.4M
    IVF
    INVO Fertility, Inc.
    0.02x -- $1.8M -$2.6M
  • Which has Higher Returns AVNS or NMTC?

    NeuroOne Medical Technologies Corp. has a net margin of -0.79% compared to Avanos Medical, Inc.'s net margin of -59.08%. Avanos Medical, Inc.'s return on equity of -52.63% beat NeuroOne Medical Technologies Corp.'s return on equity of -89.54%.

    Company Gross Margin Earnings Per Share Invested Capital
    AVNS
    Avanos Medical, Inc.
    45.61% -$0.03 $911.7M
    NMTC
    NeuroOne Medical Technologies Corp.
    55.77% -$0.03 $7.3M
  • What do Analysts Say About AVNS or NMTC?

    Avanos Medical, Inc. has a consensus price target of $14.00, signalling upside risk potential of 13.36%. On the other hand NeuroOne Medical Technologies Corp. has an analysts' consensus of $2.30 which suggests that it could grow by 162.56%. Given that NeuroOne Medical Technologies Corp. has higher upside potential than Avanos Medical, Inc., analysts believe NeuroOne Medical Technologies Corp. is more attractive than Avanos Medical, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    AVNS
    Avanos Medical, Inc.
    0 1 0
    NMTC
    NeuroOne Medical Technologies Corp.
    1 0 0
  • Is AVNS or NMTC More Risky?

    Avanos Medical, Inc. has a beta of 1.079, which suggesting that the stock is 7.932% more volatile than S&P 500. In comparison NeuroOne Medical Technologies Corp. has a beta of 0.575, suggesting its less volatile than the S&P 500 by 42.534%.

  • Which is a Better Dividend Stock AVNS or NMTC?

    Avanos Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avanos Medical, Inc. pays -- of its earnings as a dividend. NeuroOne Medical Technologies Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios AVNS or NMTC?

    Avanos Medical, Inc. quarterly revenues are $177.8M, which are larger than NeuroOne Medical Technologies Corp. quarterly revenues of $2.7M. Avanos Medical, Inc.'s net income of -$1.4M is higher than NeuroOne Medical Technologies Corp.'s net income of -$1.6M. Notably, Avanos Medical, Inc.'s price-to-earnings ratio is 45.94x while NeuroOne Medical Technologies Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avanos Medical, Inc. is 0.82x versus 2.91x for NeuroOne Medical Technologies Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    AVNS
    Avanos Medical, Inc.
    0.82x 45.94x $177.8M -$1.4M
    NMTC
    NeuroOne Medical Technologies Corp.
    2.91x -- $2.7M -$1.6M
  • Which has Higher Returns AVNS or NTRB?

    Nutriband, Inc. has a net margin of -0.79% compared to Avanos Medical, Inc.'s net margin of -1118.87%. Avanos Medical, Inc.'s return on equity of -52.63% beat Nutriband, Inc.'s return on equity of -164.64%.

    Company Gross Margin Earnings Per Share Invested Capital
    AVNS
    Avanos Medical, Inc.
    45.61% -$0.03 $911.7M
    NTRB
    Nutriband, Inc.
    18.2% -$0.32 $7.8M
  • What do Analysts Say About AVNS or NTRB?

    Avanos Medical, Inc. has a consensus price target of $14.00, signalling upside risk potential of 13.36%. On the other hand Nutriband, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 243.25%. Given that Nutriband, Inc. has higher upside potential than Avanos Medical, Inc., analysts believe Nutriband, Inc. is more attractive than Avanos Medical, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    AVNS
    Avanos Medical, Inc.
    0 1 0
    NTRB
    Nutriband, Inc.
    1 0 0
  • Is AVNS or NTRB More Risky?

    Avanos Medical, Inc. has a beta of 1.079, which suggesting that the stock is 7.932% more volatile than S&P 500. In comparison Nutriband, Inc. has a beta of 1.840, suggesting its more volatile than the S&P 500 by 84.015%.

  • Which is a Better Dividend Stock AVNS or NTRB?

    Avanos Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avanos Medical, Inc. pays -- of its earnings as a dividend. Nutriband, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios AVNS or NTRB?

    Avanos Medical, Inc. quarterly revenues are $177.8M, which are larger than Nutriband, Inc. quarterly revenues of $346.1K. Avanos Medical, Inc.'s net income of -$1.4M is higher than Nutriband, Inc.'s net income of -$3.9M. Notably, Avanos Medical, Inc.'s price-to-earnings ratio is 45.94x while Nutriband, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avanos Medical, Inc. is 0.82x versus 21.81x for Nutriband, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    AVNS
    Avanos Medical, Inc.
    0.82x 45.94x $177.8M -$1.4M
    NTRB
    Nutriband, Inc.
    21.81x -- $346.1K -$3.9M
  • Which has Higher Returns AVNS or NVNO?

    enVVeno Medical Corp. has a net margin of -0.79% compared to Avanos Medical, Inc.'s net margin of --. Avanos Medical, Inc.'s return on equity of -52.63% beat enVVeno Medical Corp.'s return on equity of -57.7%.

    Company Gross Margin Earnings Per Share Invested Capital
    AVNS
    Avanos Medical, Inc.
    45.61% -$0.03 $911.7M
    NVNO
    enVVeno Medical Corp.
    -- -$0.23 $30.2M
  • What do Analysts Say About AVNS or NVNO?

    Avanos Medical, Inc. has a consensus price target of $14.00, signalling upside risk potential of 13.36%. On the other hand enVVeno Medical Corp. has an analysts' consensus of $12.50 which suggests that it could grow by 3372.22%. Given that enVVeno Medical Corp. has higher upside potential than Avanos Medical, Inc., analysts believe enVVeno Medical Corp. is more attractive than Avanos Medical, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    AVNS
    Avanos Medical, Inc.
    0 1 0
    NVNO
    enVVeno Medical Corp.
    0 1 0
  • Is AVNS or NVNO More Risky?

    Avanos Medical, Inc. has a beta of 1.079, which suggesting that the stock is 7.932% more volatile than S&P 500. In comparison enVVeno Medical Corp. has a beta of 1.040, suggesting its more volatile than the S&P 500 by 4.044%.

  • Which is a Better Dividend Stock AVNS or NVNO?

    Avanos Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. enVVeno Medical Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avanos Medical, Inc. pays -- of its earnings as a dividend. enVVeno Medical Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios AVNS or NVNO?

    Avanos Medical, Inc. quarterly revenues are $177.8M, which are larger than enVVeno Medical Corp. quarterly revenues of --. Avanos Medical, Inc.'s net income of -$1.4M is higher than enVVeno Medical Corp.'s net income of -$4.5M. Notably, Avanos Medical, Inc.'s price-to-earnings ratio is 45.94x while enVVeno Medical Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avanos Medical, Inc. is 0.82x versus 473.07x for enVVeno Medical Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    AVNS
    Avanos Medical, Inc.
    0.82x 45.94x $177.8M -$1.4M
    NVNO
    enVVeno Medical Corp.
    473.07x -- -- -$4.5M
  • Which has Higher Returns AVNS or SINT?

    SINTX Technologies, Inc. has a net margin of -0.79% compared to Avanos Medical, Inc.'s net margin of -1701.44%. Avanos Medical, Inc.'s return on equity of -52.63% beat SINTX Technologies, Inc.'s return on equity of -208.36%.

    Company Gross Margin Earnings Per Share Invested Capital
    AVNS
    Avanos Medical, Inc.
    45.61% -$0.03 $911.7M
    SINT
    SINTX Technologies, Inc.
    -31.73% -$3.46 $7.5M
  • What do Analysts Say About AVNS or SINT?

    Avanos Medical, Inc. has a consensus price target of $14.00, signalling upside risk potential of 13.36%. On the other hand SINTX Technologies, Inc. has an analysts' consensus of $12.25 which suggests that it could grow by 224.07%. Given that SINTX Technologies, Inc. has higher upside potential than Avanos Medical, Inc., analysts believe SINTX Technologies, Inc. is more attractive than Avanos Medical, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    AVNS
    Avanos Medical, Inc.
    0 1 0
    SINT
    SINTX Technologies, Inc.
    2 0 0
  • Is AVNS or SINT More Risky?

    Avanos Medical, Inc. has a beta of 1.079, which suggesting that the stock is 7.932% more volatile than S&P 500. In comparison SINTX Technologies, Inc. has a beta of 0.649, suggesting its less volatile than the S&P 500 by 35.053%.

  • Which is a Better Dividend Stock AVNS or SINT?

    Avanos Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SINTX Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avanos Medical, Inc. pays -- of its earnings as a dividend. SINTX Technologies, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios AVNS or SINT?

    Avanos Medical, Inc. quarterly revenues are $177.8M, which are larger than SINTX Technologies, Inc. quarterly revenues of $208K. Avanos Medical, Inc.'s net income of -$1.4M is higher than SINTX Technologies, Inc.'s net income of -$3.5M. Notably, Avanos Medical, Inc.'s price-to-earnings ratio is 45.94x while SINTX Technologies, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avanos Medical, Inc. is 0.82x versus 6.41x for SINTX Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    AVNS
    Avanos Medical, Inc.
    0.82x 45.94x $177.8M -$1.4M
    SINT
    SINTX Technologies, Inc.
    6.41x -- $208K -$3.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Shopify Stock a Good Buy Now?
Is Shopify Stock a Good Buy Now?

eCommerce technology platform Shopify (NASDAQ:SHOP) delivered impressive returns in 2025…

Will The Magnificent 7 Stocks Go Up This Year?
Will The Magnificent 7 Stocks Go Up This Year?

2025 was another banner year for the Magnificent Seven stocks,…

Why Did Planet Labs Stock Rally So Much?
Why Did Planet Labs Stock Rally So Much?

Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
100
ATGL alert for Jan 10

Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.

Buy
71
NAIL alert for Jan 10

Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.

Buy
54
LGIH alert for Jan 10

LGI Homes, Inc. [LGIH] is up 13.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock